A promising vaccine fails to provide durable protection against infection and clinical malaria in infants, a key malaria vaccine target population, in a phase 2b clinical trial. The need for a highly effective vaccine against malaria remains as urgent as ever.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Anti-Plasmodium vivax merozoite surface protein 3 ϒ (PvMSP3 ϒ) antibodies upon natural infection
Scientific Reports Open Access 26 April 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Oneko, M. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01470-y (2021).
Luke, T. C. & Hoffman, S. L. J. Exp. Biol. 206, 3803–3808 (2003).
Epstein, J. E. et al. Science 334, 475–480 (2011).
Seder, R. A. et al. Science 341, 1359–1365 (2013).
Sissoko, M. S. et al. Lancet Infect. Dis. 17, 498–509 (2017).
Jongo, S. A. et al. Am. J. Trop. Med. Hyg. 100, 1433–1444 (2019).
Suscovich, T. J. et al. Sci. Transl. Med. 12, eabb4757 (2020).
Genton, B. et al. J. Infect. Dis. 185, 820–827 (2002).
Datoo, M. S. et al. Lancet 397, 1809–1818 (2021).
Gaudinski, M. R. et al. N. Engl. J. Med. 385, 803–814 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Nkumama, I.N., Osier, F.H.A. Malaria vaccine roller coaster. Nat Microbiol 6, 1345–1346 (2021). https://doi.org/10.1038/s41564-021-00982-0
Published:
Issue date:
DOI: https://doi.org/10.1038/s41564-021-00982-0
This article is cited by
-
Anti-Plasmodium vivax merozoite surface protein 3 ϒ (PvMSP3 ϒ) antibodies upon natural infection
Scientific Reports (2024)